On November 20, 2023, in connection with the Dissolution, Evelo Biosciences, Inc. announced that Simba Gill ceased serving as the Company?s Chief Executive Officer, principal executive officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 USD | +9,900.00% | +9,900.00% | -2.44% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-2.44% | 1.14M | |
+18.15% | 124B | |
+18.02% | 112B | |
+3.73% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-16.54% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- EVLO Stock
- News Evelo Biosciences, Inc.
- Evelo Biosciences, Inc. Announces Simba Gill Ceases as Chief Executive Officer